We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
377 result(s) found, displaying 51 to 60
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEXAMETHASONE JUNO dexamethasone phosphate (as dexamethasone sodium phosphate) 8 mg/2 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ESMOLOL JUNO esmolol hydrochloride 100 mg/10 mL solution for injection vial.
-
Prescription medicine registrationActive ingredients: fosaprepitant dimeglumine.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FENTANYL JUNO fentanyl (as citrate) 500 microgram/10 mL injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FENTANYL JUNO fentanyl (as citrate) 100 microgram/2 mL injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATROPINE JUNO atropine sulfate monohydrate 600 microgram/1mL injection BP ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATROPINE JUNO atropine sulfate monohydrate 400 microgram/1mL injection BP ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATROPINE JUNO atropine sulfate monohydrate 500 microgram/1mL injection BP ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATROPINE JUNO atropine sulfate monohydrate 1.2mg/1mL injection BP ampoule.
-
Prescription medicine decision summaryExarane (enoxaparin sodium) is approved to prevent and/or treat thromboembolic disorders, angina and non-Q-wave myocardial infarction and ST-segment Elevation Myocardial Infarction.